Brief: Vyant Bio Announces Issuance Of Key Patent For High-Throughput Optical Assay Of Human Mixed Cell Population Spheroids
13/07/2021 13:24
July 13 (Reuters) - Vyant Bio Inc VYNT.O :
* VYANT BIO ANNOUNCES ISSUANCE OF KEY PATENT FOR
HIGH-THROUGHPUT
OPTICAL ASSAY OF HUMAN MIXED CELL POPULATION SPHEROIDS
Source text for Eikon: ID:nGNX7Mp0ZX
Further company coverage: VYNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration